Madrigal Pharmaceuticals, Inc. (MDGL)
NASDAQ: MDGL · Real-Time Price · USD
327.94
+10.85 (3.42%)
Nov 21, 2024, 1:34 PM EST - Market open
Madrigal Pharmaceuticals Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Nov '24 Nov 21, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 7,153 | 4,568 | 5,179 | 1,449 | 1,719 | 1,406 | |
| Market Cap Growth | 70.82% | -11.79% | 257.45% | -15.74% | 22.31% | -18.98% | |
| Enterprise Value | 6,036 | 4,452 | 5,075 | 1,151 | 1,384 | 953 | |
| Last Close Price | 317.09 | 231.38 | 290.25 | 84.74 | 111.17 | 91.11 | |
| PB Ratio | 8.90 | 11.27 | 26.24 | 7.39 | 7.17 | 3.37 | |
| P/TBV Ratio | 5.97 | 11.27 | 26.24 | 7.39 | 7.17 | 3.37 | |
| Debt / Equity Ratio | 0.15 | 0.29 | 0.25 | 0.00 | 0.00 | 0.00 | |
| Quick Ratio | 5.79 | 5.35 | 3.10 | 3.52 | 6.10 | 17.47 | |
| Current Ratio | 5.98 | 5.38 | 3.12 | 3.54 | 6.13 | 17.52 | |
| Return on Equity (ROE) | -129.76% | -123.98% | -150.12% | -110.92% | -61.61% | -18.79% | |
| Return on Assets (ROA) | -52.25% | -47.41% | -57.71% | -54.09% | -35.44% | -12.80% | |
| Return on Capital (ROIC) | -66.18% | -61.78% | -82.62% | -69.26% | -39.26% | -13.28% | |
| Earnings Yield | -7.23% | -8.18% | -5.70% | -16.69% | -11.76% | -5.97% | |
| FCF Yield | -6.04% | -7.13% | -4.35% | -12.71% | -9.18% | -2.97% | |
| Buyback Yield / Dilution | -14.83% | -9.05% | -3.64% | -7.05% | -0.34% | -4.04% | |
| Total Shareholder Return | -14.83% | -9.05% | -3.64% | -7.05% | -0.34% | -4.04% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.